✦ LIBER ✦

Prevention of osteoporosis as a consequence of aromatase inhibitor therapy in postmenopausal women with early breast cancer: Rationale and design of a randomized controlled trial

✍ Scribed by Sharon Kilbreath; Kathryn M. Refshauge; Jane Beith; Leigh Ward; Kate Sawkins; Ross Paterson; Philip Clifton-Bligh; Philip N. Sambrook; Judy M. Simpson; Liza Nery

Book ID: 116351024
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 168 KB
Volume: 32
Category: Article
ISSN: 1551-7144
DOI: 10.1016/j.cct.2011.04.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New aromatase inhibitors as second-line

New aromatase inhibitors as second-line endocrine therapy in postmenopausal patients with metastatic breast carcinoma : A pooled analysis of the randomized trials

✍ Paolo Carlini; Emilio Bria; Diana Giannarelli; Gianluigi Ferretti; Alessandra Fe 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 2 views

Double-Blind, Randomized Placebo Control

Double-Blind, Randomized Placebo Controlled Trial of Fulvestrant Compared With Exemestane After Prior Nonsteroidal Aromatase Inhibitor Therapy in Postmenopausal Women With Hormone Receptor–Positive, Advanced Breast Cancer: Results From EFECT

✍ Chia, Y.H.; Ma, C.X. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 60 KB

PCN69 Cost-Effectiveness Analysis of Aro

PCN69 Cost-Effectiveness Analysis of Aromatase Inhibitors and Tamoxifen As an Adjuvant Therapy in Postmenopausal Women with Early-Stage Hormone Receptor Positive Breast Cancer

✍ Sura, S.D.; Sansgiry, S.S. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Zoledronic acid for treatment of osteope

Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy

✍ Stephanie L. Hines; Jeff A. Sloan; Pamela J. Atherton; Edith A. Perez; Shaker R. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Randomized controlled trial of toremifen

Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer

✍ Yutaka Yamamoto, Takashi Ishikawa, Yasuo Hozumi, Masahiko Ikeda, Hiroji Iwata… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 211 KB

3. A randomized trial of the new specifi

3. A randomized trial of the new specific aromatase inhibitor ‘Arimidex’ (anastrozole) versus megestrol acetate (MA) in the treatment of postmenopausal women with advanced breast cancer (ABC)

✍ W. Jonat; A. Howell; C.P. Blomqvist; W. Eiermann; G. Winblad; C.J. Tyrrell; L. M 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 435 KB